Title: Detection of Diabetes Mellitus Using HbA1C as Diagnostic Criteria

Authors: Dr Saurbh Tomar, Dr Manisha Chauhan

 DOI:  http://dx.doi.org/10.18535/jmscr/v4i3.21

Abstract

Background: The evidence base in support of HbA1c (glycosylated Hemoglobin) as a diagnostic test for diabetes mellitus is focused on predicting a clinical outcome, considered to be the pinnacle of the Stockholm Hierarchy applied to reference intervals and clinical decision limits. In the case of diabetes, the major outcome of interest is the long term microvascular complications for which a large body of data has been accumulated, leading to the endorsement of HbA1c for diagnosis in many countries worldwide, with some variations in cut-offs and testing strategies.

Aims: To assess the role of Glycosylated Hemoglobin (HbA1C) measurement as a diagnostic test for Diabetes mellitus and to study the relationship of HbA1c and complications of diabetes mellitus.

Materials And Methods:The present clinical study was a prospective comparative study conducted over period of 8 months. Total 1025 diabetic patients who were having symptoms suggestive of diabetes mellitus like polyuria, polyphagia, polydypsia and easy fatigability and never been diagnosed as diabetic were examined out of them 820 were excluded from the study on the basis of exclusion criteria. Remaining 205 patients who satisfied the inclusion criteria were subjected to detailed history, thorough clinical examination, fundoscopic examination and HbA1c test.

Inclusion Criteria: Patients who were having symptoms suggestive of diabetes mellitus like polyuria, polydypsia, polyphagia and easy fatigability, and never being diagnosed as diabetic.

Exclusion criteria:Patients who were already diagnosed as diabetics were excluded from the study and Patients having various conditions leading to alternation in levels of HbA1c like altered erythropoiesis, altered hemoglobin, altered glycation.

Results:Total 1025 diabetic patients were examined out of them 820 were excluded from the study on the basis of exclusion criteria. Remaining 205 patients who satisfied the inclusion criteria were subjected to detailed history, thorough clinical examination, fundoscopic examination and HbA1c test. On the basis of HbA1c as a diagnostic test for diabetes mellitus out of total 205 patients one hundred four(50.7%) were diagnosed as diabetic and one hundred one(49.3) were non diabetic. On the basis of fasting blood sugar level as a diagnostic test for diabetes mellitus out of total 205 patients. Hundred (48.8%) were diagnosed as diabetic and one hundred five(51.2) were non diabetic. On the basis of post prandial blood sugar level  as a diagnostic test for diabetes mellitus out of total 205 patients. Eighty seven(42.4%) were diagnosed as diabetic and one hundred eighteen(57.6) were non diabetic. HbA1c is a good diagnostic test. But FBS, PPBS should also be done to have accurate diagnosis of diabetes mellitus and to avoid the under dignosis and rarely over diagnosis. In this study out of two hundred five patients fourty two (20.2%) had Diabetic retinopathy as a complication and sixty two (30.2) as neuropathy as a complication. Both of these two were highly significant complications associated with higher levels of HbA1c (p value 0.000).while out of two hundred five patients. Fourteen (20%) had diabetic ketoacidosis as a complication. which shown significant association with higher levels of HbA1c.(p value 0.001).

Conclusion:HbA1c is a good diagnostic test and better predictor of glycemia related complications.

But FBS, PPBS should also be done to have accurate diagnosis of diabetes mellitus(DM) and to avoid the under dignosis and rarely over diagnosis. 

 Diabetic retinopathy, neuropathy, DKA are the complications in DM depending upon the HbA1c level. and they have got significant correlation.

References

1        Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimate for the year 2000 and projections for 2030. Diabetes Care 27: 1047–1053. View Article, PubMed/NCBI, Google Scholar

2        World Health Organizationhttp://www. who.int/diabetes/publications/Definition%20and%20diagnosis%20of%20diabetes_new.pdf, accessed 22 January 2010.

3        American Diabetes Association (2005) Diagnosis and classification of diabetes mellitus. Diabetes Care 28: [suppl1]537–542. View Article PubMed/NCBI Google Scholar

4        Melchionda N, Forlani G, Marchesini G, Baraldi L, Natale S (2002) WHO and ADA criteria for the diagnosis of diabetes mellitus in relation to body mass index. Insulin sensitivity and secretion in resulting subcategories of glucose tolerance. Int J Obes 26: 90–96. View Article, PubMed/NCBI Google Scholar

5        Sacks DB (2009) The diagnosis of diabetes is changing: how implementation of haemoglobin A1c will impact clinical laboratories. Clin Chem 55: 1612–1614. View Article PubMed/NCBI Google Scholar

6        American Diabetes AssociationDiagnosis and classification of diabetes mellitus. Diabetes Care 33: Suppl 1S62–S69. View Article PubMed/NCBI Google Scholar

7        The International Expert Committee (2009) International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care 32: 1327–1334. View Article PubMed/NCBI Google Scholar

8        Cohen RM (2009) A1c: does one size fit all? Diabetes Care 30: 2756–2758. View Article PubMed/NCBI Google Scholar

9        Young IS (2010) Counterpoint: The reporting of estimated glucose with haemoglobin A1c. Clin Chem 56: 547–549. View Article PubMed/NCBI Google Scholar

10    Bradshaw D, Norma R, Pieterse D, Levitt NS, and the South African Comparative Risk Assessment Collaborating Group (2007) Estimating the burden of disease attributable to diabetes in South Africa in 2000. S Afr Med J 97: 700–706. View Article PubMed/NCBI Google Scholar

11    11.Levitt NS, Steyn K, Lambert EV, Reagon G, Lombard CJ, et al. (1999) Modifiable risk factors for type 2 diabetes mellitus in a peri-urban community in South Africa. Diabet Med 16: 946–950. View Article PubMed/NCBI Google Scholar

12    Charlton KE, Levitt NS, Lombard CJ (1997) The prevalence of diabetes mellitus and associated factors in elderly coloured S Africans. S African Med J 87: 364–367. View Article PubMed/NCBI Google Scholar

13    Molleutze WF, Levitt NS (2006) Diabetes mellitus and impaired glucose tolerance in South Africa. In: Steyn K, Fourie J, Temple N, editors. Chronic Diseases of Lifestyle in South Africa: 1995–2005. Technical Report. Cape Town: South African medical research Council. pp. 190–12.

14    Beran D, Yudkin JS (2006) Diabetes care in sub-Saharan Africa. Lancet 368: 1689–1695. View Article, PubMed/NCBI, Google Scholar

15    The Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervention and Complications (DCCT/ EDIC) Study Research Group (2005) Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Eng J Med 353: 2643–2653. View Article PubMed/NCBI, Google Scholar

Corresponding Author

Dr Saurbh Tomar

Ex-Junior Resident, RDGMC, Ujjain (M.P.)

Senior Resident, G.R. Medical College, Gwalior (MP)

MIG-15, New Housing Board Colony, Morena-476001(M.P) NDIA

Email: This email address is being protected from spambots. You need JavaScript enabled to view it., 9165730003